Introduction
Candidiasis encompasses infections that range from superficial, such as oral thrush and vaginitis, to systemic and potentially life-threatening diseases particularly in patients undergoing anticancer chemotherapy, organ transplants, or long treatment with antimicrobial agents and in patients with AIDS because of immune system suppression. Such a broad range of infections and development of resistance to currently available antifungal agents require an equally broad range of diagnostic and therapeutic strategies.
1,2
The fungicidal activities of sulfurated compounds have been known for a long time. 3 Dithiocarbamates, which are an important class of sulfur-containing compounds, were also described as herbicides and fungicides, previously. 4−6 First, Kligman and Rosenweig determined the activity of 4 dimethyl dithiocarbamate salts against several pathogenic fungi and commented on their possible application in human therapy. 7, 8 In the last decade, dithiocarbamate moiety combined with different heterocyclic ring systems was studied widely, and now these compounds form a promising group of novel antifungal agents. 9 The dithiocarbamate-including compounds are known to act as inhibitors of enzymes and have a profound effect on biological systems, because of their strong metal-binding capacity. The well-known thiocarbamate class of antifungal drug tolciclate (I) and the fungicidal active plant defense agent brassinin (II) are famous sulfurated compounds. Additionally, * Correspondence: lyurttas@anadolu.edu.tr rhodanine (III) and its derivatives are the other dithiocarbamate-including molecules known for their ability to inhibit fungal protein mannosyl transferase 1 (PMT1), which plays a key role in the biosynthesis of the fungal cell wall of Candida (Figure) .
10,11
Figure. Thiazoles have a prominent position among heterocycles and they can be obtained from microbial and marine origins as well as by synthetic procedure. 
18−20
According to the foregoing literature survey, we now report the synthesis of the dithiocarbamic acid derivatives of N -[4-(2-methyl-4-thiazolyl)phenyl]acetamide structure with potential anticandidal activity and cytotoxicity in this study.
Results and discussion
The present study was undertaken to synthesize some thiazole derivatives bearing dithiocarbamic acid ester and to investigate their anticandidal activity and cytotoxicity. The target compounds were obtained in multistep organic synthesis as shown in the Scheme. The initial compound 4-aminoacetophenone in a TEA/THF mixture was acetylated with chloroacetyl chloride to obtain 4-(acetylamino)acetophenone (1); then compound 1 in AcOH was brominated to obtain N -[4-(2-bromoacetyl)phenyl]acetamide (2) . The obtained amide compound (2) was reacted with thioacetamide to give N -[4-(2-methyl-4-thiazolyl)phenyl]acetamide (3). After hydrolysis of the acetyl group on amino moiety, compound 4-(2-methyl-4-thiazolyl)aniline (4) was synthesized, which was then acetylated with chloroacetyl chloride to obtain 2-chloro-N -[4-(2-methyl-4-thiazolyl)phenyl]acetamide (5). In the final step, compound 5 was reacted with appropriate dithiocarbamate salts to give the final compounds (6a-6j). Compound 6c (2-[[4-(2-methyl-4-thiazolyl)phenyl]amino]-2-oxoethyl morpholine-4-carbodithioate) was synthesized and registered with the chemical abstract service before, but there are no scientific data about the molecule and so we included this compound in our research.
The structures of the synthesized compounds were elucidated by spectral data and elemental analysis, and significant stretching bands in the IR spectra were observed in the expected regions. The target compounds 6a-j were screened for their in vitro anticandidal activity against 7 candida species, including standard strains and clinical isolates. MIC is defined as the concentration of the compound required to give complete inhibition of bacterial growth and MICs of the synthesized compounds along with the reference drug ketoconazole are given. The results provided in Table 1 indicate that most of the prepared compounds displayed broad antifungal spectra with MIC values ranging from 62.5 to 125 µ g/mL against all the tested strains. Among all evaluated strains, the compounds 6a, 6b, 6c, 6f, and 6g had anticandidal activity lower than that of the standard drug. Compound 6a inhibited all species at a concentration of 62.5 µ g/mL except against C. tropicalis. Both of the compounds 6b and 6c displayed anticandidal activity against C. albicans (ATCC 90028) and C. glabrata (isolate 1) at the same concentrations (62.5 µ g/mL). Compounds were also studied for their cytotoxic properties using the MTT assay. The IC 50 (µ g/mL) values of the compounds against NIH/3T3 cells are shown in Table 2 . The biological study indicated that compound 6f possessed the highest cytotoxicity, with a value of about 30 µ g/mL, whereas compound 6i exhibited the lowest cytotoxicity, with a value of about 330 µ g/mL, against NIH/3T3 cells. 
Conclusion
In this study, we report the synthesis, spectral studies, and biological evaluation of some thiazole derivatives bearing dithiocarbamic acid ester (6a-j). The structures proposed for the synthesized compounds (6a-j) are well supported by spectroscopic data and elemental analysis. Some of the final compounds (6a, 6b, 6c, 6f, and 6g) were evaluated for their anticandidal activity and they exhibited weak activity against all tested strains. The cytotoxicity of the compounds was also studied and compounds 6c, 6d, 6h, and 6i displayed the lowest cytotoxicity against NIH/3T3 cells. 
Experimental
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA). All melting points (mps) were determined by Electrothermal 9100 digital melting point apparatus (Electrothermal, Essex, UK) and are uncorrected.
All the reactions were monitored by thin-layer chromatography (TLC) using Silica Gel 60 F254 TLC plates 
4-(2-Bromoacetyl)acetanilide (2)
Compound 1 (0.04 mol, 7.08 g) and HBr (0.5 mL) were dissolved in acetic acid (30 mL) and bromine (0.044 mol, 2.27 mL) was added dropwise at room temperature. After completion of the addition of bromine, the reaction mixture was stirred for 1 h and then poured into ice-water (100 mL). (amide C=O), 1378-1196 (C-N), and 848 (1,4-disubstituted benzene).
4-(2-Methyl-4-thiazolyl)acetanilide (3)
Compound 2 (0.03 mol, 7.68 g) and thioacetamide (0.03 mol, 2.25 g) in ethanol (100 mL) were stirred at room temperature for 48 h. The precipitated product was filtered, dried, and recrystallized from ethanol. Yield: 78%; 
4-(2-Methyl-4-thiazolyl)aniline (4)
Compound 3 (0.025 mol, 5.8 g) was refluxed in 10% HCl (100 mL) for 1 h. The mixture was cooled down, poured into ice-water (100 mL) and made basic with 10% NaOH solution. The precipitated product was (1,4-disubstituted benzene).
2-Chloro-N -[4-(2-methyl-4-thiazolyl)phenyl]acetamide (5)
Chloroacetyl chloride (0.02 mol, 1.6 mL) was added dropwise over 15 min to a magnetically stirred solution of compound 4 (0.02 mol, 3.8 g) and triethylamine (0.02 mol, 2.8 mL) in dry THF (15 mL). After completion of the reaction, the solvent was evaporated under reduced pressure. Water was added to wash the resulting solid and the mixture was filtered, dried, and recrystallized from ethanol to give compound 5. 
General methods for synthesis of compounds 6a-j
Compound 5 (0.001 mol) was stirred with appropriate sodium salts of dithiocarbamic acids (0.0011 mol) in acetone for 3 h. The precipitated product was filtered and washed with water. 
2-[[4-(2-Methyl-4-thiazolyl)phenyl]amino]-2-oxoethyl diethylcarbamodithiodate (6a)
85%
2-[[4-(2-Methyl-4-thiazolyl)phenyl]amino]-2-oxoethylthiomorpholine-4-carbodithioate (6d)
88%
Cytotoxicity assay
Cytotoxic properties of the compounds were determined by the method mentioned in the literature using mouse embryonic fibroblast (NIH/3T3) cells. 25 The calculated IC 50 values of the compounds are exhibited in Table   2 . The procedure was realized using the standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 26 NIH/3T3 cells were cultured in 96-well flat-bottom plates at 37
• C for 24 h (2 × 10 4 cells per well). All the compounds were dissolved in DMSO individually and added to culture wells at varying concentrations (0.5-500 µ g/mL); the highest final DMSO concentration was under 0.1%. After 24 h of drug incubation at 37
• C, 20 mL of MTT solution (5 mg/mL MTT powder in PBS) was added to each well. Then a 3-h incubation period was maintained in the same conditions. Purple formazan occurred at the end of the process, which is the reduction product of MTT agent by the mitochondrial dehydrogenase enzyme of intact cells. Formazan crystals were dissolved in 100 mL of DMSO and the absorbance was read by ELISA reader (OD 570 nm). The percentage of viable cells was calculated based on the medium control.
